The work Rosetrees does in supporting in excess of 250 cutting edge medical research projects is backed up by the UK Advisory Panel, a six strong group of the UK’s leading researchers. They provide an invaluable source of guidance and advice and have enabled Rosetrees to support the best in medical research and build up a worldwide database of peer reviewers who review over 200 projects a year for Rosetrees.
Our Advisory Panel is led by Professor Patrick Maxwell (Regius Professor at Cambridge), alongside Professors Molly Stevens, Roger Barker and David Katz, (who in addition provides invaluable advice throughout the year when all new applications are being considered).
The UK Advisory Panel provides the scientific and research expertise that is needed to anchor Rosetrees Venture Philanthropy approach.
Professor Patrick Maxwell
Professor Patrick Maxwell is the Chair of the Rosetrees Advisory Panel. Currently Regius Professor of Physic at Cambridge and previously The Dean of the Faculty of Medical Sciences at UCL, he is a physician scientist who is trained as a specialist in Nephrology and General (Internal) Medicine.
The Regius Professor of Physic is the Head of the School of Clinical Medicine at the University of Cambridge and plays a key role in Cambridge University Health Partners, the Academic Health Sciences Centre for Cambridge.
Patrick is an integral member of the Panel and an invaluable source of advice to Rosetrees.
Professor Molly Stevens
Professor Molly Stevens is currently Professor of Biomedical Materials and Regenerative Medicine and the Research Director for Biomedical Material Sciences in the Institute of Biomedical Engineering. She was one of the youngest Professor at Imperial and in 2010 she was recognised by The Times as one of the top ten scientists under the age of 40. In 2012 she gave the Clifford Patterson Award lecture at the Royal Society and she is regularly in the media as one of the UK’s most outstanding researchers.
She has a large and extremely multidisciplinary research group of students and postdocs/fellows. Research in regenerative medicine within her group includes the directed differentiation of stem cells, the design of novel bioactive scaffolds and new approaches towards tissue regeneration. She has developed novel approaches to tissue engineering that are likely to prove very powerful in the engineering of large quantities of human mature bone for autologous transplantation as well as other vital organs such as liver and pancreas, which have proven elusive with other approaches. She has also pioneered the development of ultrasensitive biosensors using bio-functionalised nanomaterials.
Professor Norman Williams
Consultant colorectal surgeon Professor Norman Williams became President of the Royal College of Surgeons in July 2011. He is Professor of Surgery and Director of Innovation at the Academic Surgical Unit of Barts and The London, Queen Mary’s School of Medicine and Dentistry.
His main clinical interests are sphincter preservation and reconstructive surgery, and his scientific interests are concentrated on GI motility and anorectal physiology.
Professor Williams has only recently joined the Panel and is looking forward to being part of the Rosetrees Trust’s work in funding medical research.
Professor David Katz
Professor David Katz is a member of the Advisory Panel and attends the two monthly Rosetrees Grant Committee Meetings where the recommendations of reviewers are received and final decisions made about which projects will be funded by Rosetrees. David is Emeritus Professor of Immunopathology at University College London.
His research career spans an era of increasing interest in the antigen presenting cell, and it is remarkable that the research questions which he recognised and worked on for several decades, and to which he made many notable contributions, are acknowledged today as being questions that are at the critical forefront of research into many serious diseases worldwide.
Professional Roger Barker
Professor Barker is the Professor of Clinical Neuroscience at the University of Cambridge and an Honorary Consultant in Neurology at the Addenbrooke’s Hospital in Cambridge and the Queen Elizabeth Hospital in Kings Lynn. His main interests are in the chronic diseases of the brain such as Parkinson’s disease and Huntington’s disease.
He undertakes basic research looking at why cells die in these diseases as well as new treatments including cell therapies to help cure these conditions as well as clinical research which seeks to better understand why patients with apparently the same disease vary so much.
He sees patients as part of the NHS work he does and currently co-ordinates a big European initiative to treat patients with Parkinson’s disease with cell transplants.